Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

NCT01231659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Women
Locally Advanced Metastatic Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Everolimus
DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals